AZRGF yields 1.29% · PFE yields 6.13%● Live data
📍 AZRGF pulled ahead of the other in Year 1
Combined, AZRGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AZRGF + PFE for your $10,000?
Azrieli Group Ltd operates in the real estate industry. The company operates through four segments: Retail Centers and Malls in Israel, Office and Other Space for Lease in Israel, Income-Producing Properties segment in the U.S., and Senior Housing segments. It develops, acquires, leases out, manages, and maintains malls and retails centers in Israel; and office buildings and parks for offices and high-tech industry, as well as logistic areas and storage. As of December 31, 2021, the company owned 19 malls and retail centers, and 17 income-producing properties in the office and other space in Israel; and 8 office properties in the United States. The company has 4 active senior homes in an aboveground built-up area of approximately 105 thousand square meters (sqm), including approximately 1,033 senior housing units and projects under development and construction for approximately 275 residential units in a total area of approximately 31 thousand sqm. It also engages in the e-commerce and hospitality operation; and invests in banking and financial corporations, and investment funds, as well as operates hotel. The company was incorporated in 1983 and is based in Tel Aviv, Israel. Azrieli Group Ltd is a subsidiary of Nadav Investments Inc.
Full AZRGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.